Home | Welcome to Contract Pharma   
Last Updated Thursday, August 28 2014
Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 2, 2013
Resumes Abbott’s research-based business Read More »
Published April 7, 2008
Keryx Biopharmaceuticals is restructuring in an effort to reduce its cash burn rate and re-focus its development efforts. The restructuring plan, which follows the negative outcome of the company's Phase III trial of Sulonex for the treatment of diab… Read More »
Published March 18, 2008
Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs… Read More »
Published September 26, 2007
Baxter BioPharma Solutions recently completed the lyophilization capacity expansion at their cytotoxic contract manufacturing facility in Halle, Germany. The expansion increased their total cytotoxic lyophilization capacity to four dedicated lyophili… Read More »
Published August 29, 2007
PDL BioPharma, Inc., following a business and portfolio review, has changed its strategic focus to the discovery and development of novel antibodies in oncology and select immunological diseases. According to a company statement, it will realign its… Read More »
Published April 11, 2006
Array BioPharma and AstraZeneca have selected a third compound for their small molecule MEK anti-cancer program, triggering a $1 million milestone payment by AstraZeneca. The second compound was selected in January 2006, also triggering a $1 million… Read More »
Published January 4, 2006
Wyeth Pharmaceuticals and Trubion Pharmaceuticals, Inc. have formed a strategic alliance for the discovery, development and commercialization of novel biopharmaceutical products to treat inflammatory disease and cancer. The alliance will utilize Trub… Read More »
Published June 3, 2014
U.S. biopharma has a good image, according to APCO’s latest study, but proactive attention to policymakers and healthcare providers may be helpful Read More »
Published May 29, 2014
To assess the dosing and performance of a subunit antigen vaccine candidate Read More »
ARL BioPharma, Inc.
By Greg Thomas, VP Business Development
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On